A new drug target for iron disorders? Intensive type 2 diabetes treatment fraught with dangerLow HbA1c levels and insulin-based therapy are linked with increased mortality in British database Chemo- trastuzumab combo ups survival Nilotinib bests imatinib in chronic myeloid leukemia Questions about tolerability and cost of treatment need answering before clinical practice should change Study OKs dose boost for estrogen receptor antagonist Tai chi qigong boosts COPD lung function Participants showed greater improvements in symptoms and activity levels compared with exercise and control groups A legacy of athleticism, passion and fair play Dr. Randy Gregg reflects on his Olympic hockey experiences as two of his children prepare for the 2010 Winter Games Dabigatran lowers deep vein clot risk Newer drug compares well with warfarin and does not require lab monitoring The tricky case for med school ranking transparency Catheter ablation tops medications in atrial fibrillation First Previous 408 409 410 411 412 Next Last
